Patient info Open main menu

Edistride - patient leaflet, side effects, dosage

Contains active substance:

Dostupné balení:

Patient leaflet - Edistride

B. PACKAGE LEAFLET

Package leaflet: Information for the patient

Edistride 5 mg film-coated tablets

Edistride 10 mg film-coated tablets dapagliflozin

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • – Keep this leaflet. You may need to read it again.

  • – If you have any further questions, ask your doctor, pharmacist or nurse.

  • – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,

even if their signs of illness are the same as yours.

  • – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side

effects not listed in this leaflet. See section 4.

What is in this leaflet

  • 1. What Edistride is and what it is used for

  • 2. What you need to know before you take Edistride

  • 3. How to take Edistride

  • 4. Possible side effects

  • 5. How to store Edistride

  • 6. Contents of the pack and other information

1.     What Edistride is and what it is used for

What Edistride is

Edistride contains the active substance dapagliflozin. It belongs to a group of medicines called “sodium glucose co-transporter-2 (SGLT2) inhibitors”. They work by blocking the SGLT2 protein in your kidney. By blocking this protein, blood sugar (glucose), salt (sodium) and water are removed from your body via the urine.

What Edistride is used for

Edistride is used to treat:

  • Type 2 diabetes
  • – in adults and children aged 10 years and older.

  • – if your type 2 diabetes cannot be controlled with diet and exercise.

  • – Edistride can be used on its own or together with other medicines to treat diabetes.

  • – It is important to continue to follow the advice on diet and exercise given to you by your

doctor, pharmacist or nurse.

  • Heart failure
  • – in adults (aged 18 years and older) with symptoms due to a weak pump function of the

heart.

  • Chronic kidney disease

– in adults with reduced kidney function.

What is type 2 diabetes and how does Edistride help?

  • In type 2 diabetes your body does not make enough insulin or is not able to use the insulin it

makes properly. This leads to a high level of sugar in your blood. This can lead to serious problems like heart or kidney disease, blindness, and poor circulation in your arms and legs.

  • Edistride works by removing excess sugar from your body. It can also help prevent heart

disease.

What is heart failure and how does Edistride help?

  • This type of heart failure occurs when the heart is weak and cannot pump enough blood to the

lungs and the rest of the body. This can lead to serious medical problems and need for hospital care.

  • The most common symptoms of heart failure are feeling breathless, feeling tired or very tired all

the time, and ankle swelling.

  • Edistride helps protect your heart from getting weaker and improves your symptoms. It can

lower the need to go to hospital and can help some patients to live longer.

What is chronic kidney disease and how does Edistride help?

  • When you have chronic kidney disease, your kidneys may gradually lose their function. This

means they would not be able to clean and filter your blood the way they should. Loss of kidney function can lead to serious medical problems and need for hospital care.

  • Edistride helps protect your kidneys from losing their function. That can help some patients live

longer.

2. What you need to know before you take Edistride

Do not take Edistride

  • if you are allergic to dapagliflozin or any of the other ingredients of this medicine (listed in

section 6).

Warnings and precautions

Contact a doctor or the nearest hospital straight away

Diabetic ketoacidosis:

  • If you have diabetes and experience feeling sick or being sick, stomach pain, excessive thirst,

fast and deep breathing, confusion, unusual sleepiness or tiredness, a sweet smell to your breath, a sweet or metallic taste in your mouth, or a different odour to your urine or sweat or rapid weight loss.

  • The above symptoms could be a sign of “diabetic ketoacidosis” – a rare but serious, sometimes

life-threatening problem you can get with diabetes because of increased levels of “ketone bodies” in your urine or blood, seen in tests.

  • The risk of developing diabetic ketoacidosis may be increased with prolonged fasting, excessive

alcohol consumption, dehydration, sudden reductions in insulin dose, or a higher need of insulin due to major surgery or serious illness.

  • When you are treated with Edistride, diabetic ketoacidosis can occur even if your blood sugar is

normal.

If you suspect you have diabetic ketoacidosis, contact a doctor or the nearest hospital straight away and do not take this medicine.

Necrotising fasciitis of the perineum:

  • Talk to your doctor immediately if you develop a combination of symptoms of pain, tenderness,

redness, or swelling of the genitals or the area between the genitals and the anus with fever or feeling generally unwell. These symptoms could be a sign of a rare but serious or even life-threatening infection, called necrotising fasciitis of the perineum or Fournier’s gangrene which destroys the tissue under the skin. Fournier’s gangrene has to be treated immediately.

Talk to your doctor, pharmacist or nurse before taking Edistride

  • if you have “type 1 diabetes” – the type that usually starts when you are young, and your body

does not produce any insulin.

  • if you have diabetes and have a kidney problem – your doctor may ask you to take additional or

a different medicine to control your blood sugar.

  • if you have a liver problem – your doctor may start you on a lower dose.
  • if you are on medicines to lower your blood pressure (anti-hypertensives) and have a history of

low blood pressure (hypotension). More information is given below under ‘Other medicines and Edistride’.

  • if you have very high levels of sugar in your blood which may make you dehydrated (lose too

much body fluid). Possible signs of dehydration are listed in section 4. Tell your doctor before you start taking Edistride if you have any of these signs.

  • if you have or develop nausea (feeling sick), vomiting or fever or if you are not able to eat or

drink. These conditions can cause dehydration. Your doctor may ask you to stop taking Edistride until you recover to prevent dehydration.

  • if you often get infections of the urinary tract. This medicine may cause urinary tract infections

and your doctor may want to monitor you more closely. Your doctor may consider temporarily changing your treatment if you develop a serious infection.

If any of the above applies to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking Edistride.

Diabetes and foot care

If you have diabetes, it is important to check your feet regularly and adhere to any other advice regarding foot care given by your health care professional.

Urine glucose

Because of how Edistride works, your urine will test positive for sugar while you are on this medicine.

Elderly (> 65 years and above)

If you are elderly, there may be a higher risk that your kidneys function less well and that you are treated with other medicines (see also ‘Kidney function’ above and ‘Other medicines and Edistride’ below).

Children and adolescents

Edistride can be used in children aged 10 years and older for the treatment of type 2 diabetes. No data are available in children below 10 years of age.

Edistride is not recommended for children and adolescents under 18 years of age for the treatment of heart failure or for the treatment of chronic kidney disease, because it has not been studied in these patients.

Other medicines and Edistride

Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.

Especially tell your doctor:

  • if you are taking a medicine used to remove water from the body (diuretic).
  • if you are taking other medicines that lower the amount of sugar in your blood such as insulin or

a “sulphonylurea” medicine. Your doctor may want to lower the dose of these other medicines, to prevent you from getting low blood sugar levels (hypoglycaemia).

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. You should stop taking this medicine if you become pregnant, since it is not recommended during the second and third trimesters of pregnancy. Talk to your doctor about the best way to control your blood sugar while you are pregnant.

Talk to your doctor if you would like to or are breast-feeding before taking this medicine. Do not use Edistride if you are breast-feeding. It is not known if this medicine passes into human breast milk.

Driving and using machines

Edistride has no or negligible influence on the ability to drive and use machines.

Taking this medicine with other medicines called sulphonylureas or with insulin can cause too low blood sugar levels (hypoglycaemia), which may cause symptoms such as shaking, sweating and change in vision, and may affect your ability to drive and use machines.

Do not drive or use any tools or machines, if you feel dizzy taking Edistride.

Edistride contains lactose

Edistride contains lactose (milk sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

3. How to take Edistride

Always take this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.

How much to take

  • The recommended dose is one 10 mg tablet each day.
  • Your doctor may start you on a 5 mg dose if you have a liver problem.
  • Your doctor will prescribe the strength that is right for you.

Taking this medicine

  • Swallow the tablet whole with half a glass of water.
  • You can take your tablet with or without food.
  • You can take the tablet at any time of the day. However, try to take it at the same time each day.

This will help you to remember to take it.

Your doctor may prescribe Edistride together with other medicine(s). Remember to take these other medicine(s) as your doctor has told you. This will help get the best results for your health.

Diet and exercise can help your body use its blood sugar better. If you have diabetes, it is important to stay on any diet and exercise program recommended by your doctor while taking Edistride.

If you take more Edistride than you should

If you take more Edistride tablets than you should, talk to a doctor or go to a hospital immediately. Take the medicine pack with you.

If you forget to take Edistride

What to do if you forget to take a tablet depends on how long it is until your next dose.

  • If it is 12 hours or more until your next dose, take a dose of Edistride as soon as you remember.

Then take your next dose at the usual time.

  • If it is less than 12 hours until your next dose, skip the missed dose. Then take your next dose at

the usual time.

  • Do not take a double dose of Edistride to make up for a forgotten dose.

If you stop taking Edistride

Do not stop taking Edistride without talking to your doctor first. If you have diabetes, your blood sugar may increase without this medicine.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Contact a doctor or the nearest hospital straight away if you have any of the following side effects:

  • angioedema, seen very rarely (may affect up to 1 in 10,000 people).

These are signs of angioedema:

  • – swelling of the face, tongue or throat

  • – difficulties swallowing

  • – hives and breathing problems

  • diabetic ketoacidosis – this is rare in patients with type 2 diabetes (may affect up to 1 in

1,000 people).

These are the signs of diabetic ketoacidosis (see also section 2 Warnings and precautions):

  • – increased levels of “ketone bodies” in your urine or blood

  • – feeling sick or being sick

  • – stomach pain

  • – excessive thirst

  • – fast and deep breathing

  • – confusion

  • – unusual sleepiness or tiredness

  • – a sweet smell to your breath, a sweet or metallic taste in your mouth or a different odour to your urine or sweat

  • – rapid weight loss.

This may occur regardless of blood sugar level. Your doctor may decide to temporarily or permanently stop your treatment with Edistride.

  • necrotising fasciitis of the perineum or Fournier’s gan­grene, a serious soft tissue infection of

the genitals or the area between the genitals and the anus, seen very rarely.

Stop taking Edistride and see a doctor as soon as possible if you notice any of the following serious side effects:

  • urinary tract infection, seen commonly (may affect up to 1 in 10 people).

These are signs of a severe infection of the urinary tract: – fever and/or chills

  • – burning sensation when passing water (urinating)

  • – pain in your back or side.

Although uncommon, if you see blood in your urine, tell your doctor immediately.

Contact your doctor as soon as possible if you have any of the following side effects:

  • low blood sugar levels (hypoglycaemia), seen very commonly (may affect more than 1 in
  • 10 people) in patients with diabetes taking this medicine with a sulphonylurea or insulin. These are the signs of low blood sugar:

  • – shaking, sweating, feeling very anxious, fast heart beat

  • – feeling hungry, headache, change in vision

  • – a change in your mood or feeling confused.

Your doctor will tell you how to treat low blood sugar levels and what to do if you get any of the signs above.

Other side effects when taking Edistride:

Common

  • genital infection (thrush) of your penis or vagina (signs may include irritation, itching, unusual

discharge or odour)

  • back pain
  • discomfort when passing water (urine), passing more water than usual or needing to pass water

more often

  • changes in the amount of cholesterol or fats in your blood (shown in tests)
  • increases in the amount of red blood cells in your blood (shown in tests)
  • decreases in creatinine renal clearance (shown in tests) in the beginning of treatment
  • dizziness
  • rash

Uncommon (may affect up to 1 in 100 people)

  • fungal infection
  • loss of too much fluid from your body (dehydration, signs may include very dry or sticky

mouth, passing little or no urine or fast heartbeat)

  • thirst
  • constipation
  • awakening from sleep at night to pass urine
  • dry mouth
  • weight decreased
  • increases in creatinine (shown in laboratory blood tests) in the beginning of treatment
  • increases in urea (shown in laboratory blood tests)

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed inBy reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Edistride

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date, which is stated on the blister or carton after ‘EXP’. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Edistride contains

  • The active substance is dapagliflozin.

Each Edistride 5 mg film-coated tablet (tablet) contains dapagliflozin propanediol monohydrate equivalent to 5 mg dapagliflozin.

Each Edistride 10 mg film-coated tablet (tablet) contains dapagliflozin propanediol monohydrate equivalent to 10 mg dapagliflozin.

  • The other ingredients are:
  • – tablet core: microcrystalline cellulose (E460i), lactose (see section 2 ‘Edistride contains lactose’), crospovidone (E1202), silicon dioxide (E551), magnesium stearate (E470b).

  • – film-coating: poly(vinyl alcohol) (E1203), titanium dioxide (E171), macrogol (3350) (E1521), talc (E553b), yellow iron oxide (E172).

What Edistride looks like and contents of the pack

Edistride 5 mg film-coated tablets are yellow and round with diameter of 0.7 cm. They have “5” on one side and “1427” on the other side.

Edistride 10 mg film-coated tablets are yellow and diamond-shaped approximately 1.1 × 0.8 cm diagonally. They have “10” on one side and “1428” on the other side.

Edistride 5 mg tablets and Edistride 10 mg tablets are available in aluminium blisters in pack sizes of 14, 28 or 98 film-coated tablets in non-perforated calendar blisters and 30×1 or 90×1 film-coated tablets in perforated unit dose blisters.

Not all pack sizes may be marketed in your country.

Marketing Authorisation Holder

AstraZeneca AB

SE-151 85 Södertälje

Sweden

Manufacturer

AstraZeneca AB

Gärtunavägen

SE-151 85 Södertälje

Sweden

AstraZeneca GmbH

Tinsdaler Weg 183

22880 Wedel

Germany

AstraZeneca UK Limited

Silk Road Business Park

Macclesfield

SK10 2NA

United Kingdom

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

Belgie/Belgiqu­e/Belgien

AstraZeneca S.A./N.V.

Tel: +32 2 370 48 11

Lietuva

UAB AstraZeneca Lietuva

Tel: +370 5 2660550

Efcarapua

Luxembourg/Lu­xemburg

Acmpa3eHeKa Etarapua EOOfl

AstraZeneca S.A./N.V.

Tea.: +359 (2) 44 55 000

Tel/Tel: +32 2 370 48 11

Česká republika

Magyarorszag

AstraZeneca Czech Republic s.r.o.

AstraZeneca Kft.

Tel: +420 222 807 111

Tel.: +36 1 883 6500

Danmark

Malta

AstraZeneca A/S

Associated Drug Co. Ltd

Tlf: +45 43 66 64 62

Tel: +356 2277 8000

Deutschland

Nederland

AstraZeneca GmbH

AstraZeneca BV

Tel: +49 41 03 7080

Tel: +31 79 363 2222

Eesti

Norge

AstraZeneca

AstraZeneca AS

Tel: +372 6549 600

Tlf: +47 21 00 64 00

EXXáSa

Österreich

AstraZeneca A.E.

Tql: +3O2 106871500

AstraZeneca Österreich GmbH

Tel: +43 1 711 31 0

España

Esteve Pharmaceuticals, S.A.

Tel: +34 93 446 60 00

Polska

AstraZeneca Pharma Poland Sp. z o.o.

Tel.: +48 22 245 73 00

Laboratorio Tau, S. A.

Tel: +34 91 301 91 00

France

AstraZeneca

Tel: +33 1 41 29 40 00

Portugal

BIAL-Portela & Ca., S.A.

Tel.: +351 22 986 61 00

Hrvatska

AstraZeneca d.o.o.

Tel: +385 1 4628 000

Romania

AstraZeneca Pharma SRL

Tel: +40 21 317 60 41

Ireland

AstraZeneca Pharmaceuticals (Ireland) DAC

Tel: +353 1609 7100

Slovenija

AstraZeneca UK Limited

Tel: +386 1 51 35 600

island

Vistor hf.

Simi: +354 535 7000

Slovenská republika

AstraZeneca AB, o.z.

Tel: +421 2 5737 7777

Italia

AstraZeneca S.p.A.

Tel: +39 02 9801 1

Suomi/Finland

AstraZeneca Oy

Puh/Tel: +358 10 23 010

Kvnpog

AXeKTop Oap^aKeuTiK^ At5

TqX: +357 22490305

Sverige

AstraZeneca AB

Tel: +46 8 553 26 000

Latvija

SIA AstraZeneca Latvija

Tel: +371 67377100

United Kingdom (Northern Ireland)

AstraZeneca UK Ltd

Tel: +44 1582 836 836

This leaflet was last revised in

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site:

56

Similar medicines